Santos Carlos Eduardo Oliveira dos, Malaman Daniele, Pereira-Lima Julio Carlos
Departamento de Gastroenterologia, Santa Casa de Caridade, Bagé, RS.
Arq Gastroenterol. 2011 Oct-Dec;48(4):242-7. doi: 10.1590/s0004-28032011000400005.
Endoscopic mucosal resection is a minimally invasive technique used in the treatment of colorectal neoplasms, including early carcinomas of different size and morphology.
To evaluate procedure safety, efficacy, outcomes, and recurrence rate in endoscopic mucosal resection of colorectal lesions.
A total of 172 lesions in 156 patients were analyzed between May 2003 and May 2009. All lesions showed pit pattern suggestive of neoplasia (Kudo types III-V) at high-magnification chromocolonoscopy with indigo carmine. The lesions were evaluated for macroscopic classification, size, location, and histopathology. Lesions 20 mm or smaller were resected en bloc and lesions larger than 20 mm were removed using the piecemeal technique. Complications and recurrence were analyzed. Patients were followed up for 18 months.
There were 83 (48.2%) superficial lesions, 57 (33.1%) depressed lesions, 44 (25.6%) laterally spreading tumors, and 45 (26.2%) protruding lesions. Mean lesion size was 11.5 mm ± 9.6 mm (2 mm-60 mm). Patients' mean age was 61.6 ± 12.5 years (34-93 years). Regarding lesion site, 24 (14.0%) lesions were located in the rectum, 68 (39.5%) in the left colon, and 80 (46.5%) in the right colon (transverse, ascending, and cecum). There were 167 (97.1%) neoplasms: 142 (82.5%) adenomatous lesions, 24 (14.0%) intramucosal carcinomas, and 1 (0.6%) invasive carcinoma. En bloc resection was performed in 158 (91.9%) cases and piecemeal resection in 14 (8.1%). Bleeding occurred in 5 (2.9%) cases. Recurrence was observed in 4.1% (5/122) of cases and was associated with lesions larger than 20 mm (P<0.01), piecemeal resection (P<0.01), advanced neoplasm (P = 0.01), and carcinoma compared to adenoma (P = 0.04).
Endoscopic mucosal resection of colorectal lesions is a safe and effective procedure, with low complication and local recurrence rates. Recurrence is associated with lesions larger than 20 mm and carcinomas.
内镜黏膜切除术是一种用于治疗结直肠肿瘤的微创技术,包括不同大小和形态的早期癌。
评估结直肠病变内镜黏膜切除术的手术安全性、疗效、结果及复发率。
对2003年5月至2009年5月期间156例患者的172个病变进行分析。所有病变在高倍靛胭脂染色结肠镜检查时均显示出提示肿瘤形成的凹陷模式(工藤分型III - V型)。对病变进行宏观分类、大小、位置及组织病理学评估。直径20mm及以下的病变整块切除,直径大于20mm的病变采用分片切除技术。分析并发症及复发情况。对患者进行18个月的随访。
有83个(48.2%)浅表病变、57个(33.1%)凹陷性病变、44个(25.6%)侧向扩散肿瘤及45个(26.2%)隆起性病变。病变平均大小为11.5mm±9.6mm(2mm - 60mm)。患者平均年龄为61.6±12.5岁(34 - 93岁)。关于病变部位,24个(14.0%)病变位于直肠,68个(39.5%)位于左半结肠,80个(46.5%)位于右半结肠(横结肠、升结肠和盲肠)。有167个(97.1%)肿瘤:142个(82.5%)腺瘤性病变、24个(14.0%)黏膜内癌和1个(0.6%)浸润性癌。158例(91.9%)进行了整块切除,14例(8.1%)进行了分片切除。5例(2.9%)发生出血。4.1%(5/122)的病例观察到复发,复发与直径大于20mm的病变(P<0.01)、分片切除(P<0.01)、进展期肿瘤(P = 0.01)以及癌与腺瘤相比(P = 0.04)有关。
结直肠病变的内镜黏膜切除术是一种安全有效的手术,并发症和局部复发率低。复发与直径大于20mm的病变及癌有关。